Drug-free Activation for Primary Ovarian Insufficiency
Overview
Affiliations
Primary Ovarian Insufficiency (POI) or Diminished Ovarian Reserve (DOR) are the two conditions that affects women leading to infertility due to the lack of follicular growth and ovulation. Egg / Oocyte donation remains an option for these patients. However, with the development in Reproductive medicine various novel technologies like Ovarian Cryopreservation, Fragmentation, activation with drug treatment or even drug free autotransplantation enables the possibility of activating the pool of primordial follicles that can lead to successful pregnancy outcomes. Here, we report a case of women with POI, in which drug free activation of follicles was performed, followed by autotransplantation, which resulted in successful pregnancy. This is first case report from India that shows the procedure works and can be tried for women with POI.
Escarcega-Bordagaray J, Torres-Martinez M, Hinojosa-Gonzalez D, Ramirez-Diaz M, Fabregues F, Carmona F J Assist Reprod Genet. 2024; 41(4):989-998.
PMID: 38315420 PMC: 11052944. DOI: 10.1007/s10815-024-03046-4.
Biological therapies for premature ovarian insufficiency: what is the evidence?.
Moustaki M, Kontogeorgi A, Tsangkalova G, Tzoupis H, Makrigiannakis A, Vryonidou A Front Reprod Health. 2023; 5:1194575.
PMID: 37744287 PMC: 10512839. DOI: 10.3389/frph.2023.1194575.
The Trends and Hotspots in Premature Ovarian Insufficiency Therapy from 2000 to 2022.
Tong Y, Cheng N, Jiang X, Wang K, Wang F, Lin X Int J Environ Res Public Health. 2022; 19(18).
PMID: 36142002 PMC: 9517308. DOI: 10.3390/ijerph191811728.
Mendez M, Fabregues F, Ferreri J, Calafell J, Villarino A, Otero J J Assist Reprod Genet. 2022; 39(8):1759-1767.
PMID: 35904669 PMC: 9428073. DOI: 10.1007/s10815-022-02579-w.